QSAR studies on benzothiophene derivatives as Plasmodium falciparum N‐myristoyltransferase inhibitors: Molecular insights into affinity and selectivity
- 11 February 2020
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 83 (2) , 264-284
Abstract
Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium and transmitted by Anopheles spp. mosquitos. Due to the emerging resistance to currently available drugs, great efforts must be invested in discovering new molecular targets and drugs. N‐myristoyltransferase (NMT) is an essential enzyme to parasites and has been validated as a chemically tractable target for the discovery of new drug candidates against malaria. In this work, 2D and 3D quantitative structure–activity relationship (QSAR) studies were conducted on a series of benzothiophene derivatives as P. falciparum NMT (PfNMT) and human NMT (HsNMT) inhibitors to shed light on the molecular requirements for inhibitor affinity and selectivity. A combination of Quantitative Structure–activity Relationship (QSAR) methods, including the hologram quantitative structure–activity relationship (HQSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity index analysis (CoMSIA) models, were used, and the impacts of the molecular alignment strategies (maximum common substructure and flexible ligand alignment) and atomic partial charge methods (Gasteiger‐Hückel, MMFF94, AM1‐BCC, CHELPG, and Mulliken) on the quality and reliability of the models were assessed. The best models exhibited internal consistency and could reasonably predict the inhibitory activity against both PfNMT (HQSAR: q2/r2/r2pred = 0.83/0.98/0.81; CoMFA: q2/r2/r2pred = 0.78/0.97/0.86; CoMSIA: q2/r2/r2pred = 0.74/0.95/0.82) and HsNMT (HQSAR: q2/r2/r2pred = 0.79/0.93/0.74; CoMFA: q2/r2/r2pred = 0.82/0.98/0.60; CoMSIA: q2/r2/r2pred = 0.62/0.95/0.56). The results enabled the identification of the polar interactions (electrostatic and hydrogen‐bonding properties) as the major molecular features that affected the inhibitory activity and selectivity. These findings should be useful for the design of PfNMT inhibitors with high affinities and selectivities as antimalarial lead candidates.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (471509/2012‐4; 405330/2016‐2; 51058/2018‐0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/07600‐3; 15/21272‐4; 13/04737‐8; 15/07005‐3)
- Instituto Serrapilheira (Serra‐1708‐16250)
This publication has 73 references indexed in Scilit:
- Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivaxN-MyristoyltransferaseJournal of Medicinal Chemistry, 2012
- Spiroindolones, a Potent Compound Class for the Treatment of MalariaScience, 2010
- N-myristoyltransferase inhibitors as new leads to treat sleeping sicknessNature, 2010
- A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studiesEuropean Journal of Medicinal Chemistry, 2010
- Protein myristoylation in health and diseaseJournal of Chemical Biology, 2009
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validationJournal of Computational Chemistry, 2002
- Effect of Parameter Variations on the Effectiveness of HQSAR AnalysesQuantitative Structure-Activity Relationships, 1999
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996
- Determining atom‐centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysisJournal of Computational Chemistry, 1990